07:00 , Sep 26, 2011 |  BC Week In Review  |  Company News

Abnova Corp., Clearbridge BioMedics Pte. Ltd. deal

The companies partnered to co-develop a non-invasive "liquid biopsy" device to screen, stage, treat and monitor cancer. Clearbridge will provide its ClearCell CTChip microfiltration system to isolate, enumerate and retrieve circulating tumor cells (CTCs) from...
07:00 , Oct 2, 2006 |  BC Week In Review  |  Company News

Abnova Corp., Axela Biosensors Inc. deal

Axela and Abnova will co-develop biomarker panels for use on Axela's dotLab protein binding detection system. Abnova will generate antibodies against undisclosed targets selected by Axela. Axela will sell any biomarker panels developed, and Abnova...
08:00 , Nov 22, 2004 |  BC Week In Review  |  Company News

Abnova Corp., EMBL deal

EMBL and Abnova partnered for high throughput production of monoclonal antibodies. The deal combines EMBL's automated platform and monoclonal antibody production systems with Abnova's in-house capabilities and infrastructure for industrial-scale production of recombinant proteins. The...